LATAM FABRY DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

LATAM Fabry Disease Market, By Therapy Type (Enzyme Replacement Therapy (Agalsidase Beta (Fabrazyme), Agalsidase Alfa (Replagal), Pegunigalsidase Alfa (PRX-102, Phase III)) Chaperon Therapy (Migalastat (Galafold Phase III)), Substrate Reduction Therapy (Lucerastat (Phase III), Venglustat (Phase III))), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospitals Pharmacies, Online pharmacies, Retail Pharmacies), By Geography (Latin America)

Published In: 31 Mar, 2026
Code: CMI5249
Page number: 152
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Therapy Type
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Country
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Recent Product Launch/Approval
- Key Strategies Adopted by Market Players
- PEST Analysis
- Epidemiology
- Mergers and Acquisitions
LATAM Fabry Disease Market, By Therapy Type, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Enzyme Replacement Therapy
  - Agalsidase Beta (Fabrazyme)
  - Agalsidase Alfa (Replagal)
  - Pegunigalsidase Alfa (PRX-102, Phase III)
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
- Chaperon Therapy
  - Migalastat (Galafold Phase III)
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
- Substrate Reduction Therapy
  - Lucerastat (Phase III)
  - Venglustat (Phase III)
    - Introduction
    - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
LATAM Fabry Disease Market, By Route of Administration, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
- Parenteral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
LATAM Fabry Disease Market, By Distribution Channel, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Hospitals Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
- Online pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Mn)
LATAM Fabry Disease Market, By Country, 2021 – 2033, (USD Mn)
- Introduction
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Country, 2020 – 2033
- Latin America
  - Brazil
    - Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
  - Mexico
    - Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
  - Argentina
    - Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
  - Rest of Latin America
    - Market Size and Forecast, By Therapy Type, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Route of Administration, 2021 – 2033, (USD Mn)
    - Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Mn)
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Amicus Therapeutics, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sanofi-Aventis U.S. LLC
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - GlaxoSmithKline plc
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Mendelics
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Takeda Pharmaceuticals U.S.A., Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Teva pharmaceutical Industries Ltd
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Moderna Therapeutics Inc
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Resverlogix
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now